Nektar Therapeutics

+$0.07 (+2.06%) Today
$0.00 (0.00%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology.

CEO
Howard W. Robin
Employees
740
Headquarters
San Francisco, California
Founded
1990

NKTR Key Statistics

Market cap
644.51M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.78M
High today
$3.50
Low today
$3.31
Open price
$3.40
Volume
3.83M
52 Week high
$19.37
52 Week low
$3.30

NKTR News

Simply Wall StMay 21

Have Insiders Sold Nektar Therapeutics Shares Recently? - Simply Wall St

Anyone interested in Nektar Therapeutics ( ) should probably be aware that the CEO, President & Director, Howard Robin, recently divested US$144k worth of share

NKTR Earnings

-$0.81
-$0.54
-$0.27
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure